This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
This article has been retracted at the request of the Editor.
Fig. 1A (3rd lane; CDC) was manipulated by replicating an image of a control lane from Fig. 1C (left lane) to represent different experimental conditions.
Fig. 1D, of nuclei isolated from cells in medium (“Nuclei/Medium”), was reused in Fig. 1G in reference [1], to represent different experimental conditions (nuclei of cells treated with γ-T3; “Nuclei/γ-T3”).
Images in Fig. 5A were reused to represent different experimental conditions: curcumin uptake by KBM-5 cells treated with curcumin alone at 30 min, and curcumin uptake by KBM-5 cells treated with cyclodextrin-complexed curcumin (CDC) at 45 min.
Images from Fig. 5A were reused in Fig. 2A of Ref. [2] to represent different experimental conditions: four of the control images of cellular uptake of curcumin shown in Fig. 5A (45, 60, 120 and 180 min) are also shown in Fig. 2A (45, 60, 120 and 180 min) of Ref. [2].
The article has been retracted because the data integrity has become questionable.
References
- 1.Kannappan R, Yadav VR, Aggarwal BB. γ-Tocotrienol but not γ-tocopherol blocks STAT3 cell signaling pathway through induction of protein-tyrosine phosphatase SHP-1 and sensitizes tumor cells to chemotherapeutic agents. J Biol Chem. 2010;285:33520–33528. doi: 10.1074/jbc.M110.158378. doi: http://dx.doi.org/10.1074/jbc.M110.158378. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 2.Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol. 2010;79:330–338. doi: 10.1016/j.bcp.2009.09.003. doi: http://dx.doi.org/10.1016/j.bcp.2009.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]